Enzo Clinical Labs to Market Ikonisys Cervical Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – Enzo Biochem's Enzo Clinical Labs division will market Ikonisys' OncoFISH cervical test, under an agreement announced today.

Enzo Clinical Labs will have exclusive marketing rights for the test in New York and New Jersey. It will offer the assay to doctors requesting advanced analysis of specimens from liquid-based Pap tests to assist them in evaluating cytologic reports. Ikonisys will conduct the evaluation of the specimen using its own CellOptics platform on the Ikoniscope Digital Microscopy System for interpreting molecular signals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.